Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Sendai virus.

× No keyword cloud information.

38 in total

1. Altered budding site of a pantropic mutant of Sendai virus, F1-R, in polarized epithelial cells.

Authors: M Tashiro; M Yamakawa; K Tobita; J T Seto; H D Klenk; R Rott
Journal: J Virol Date: 1990-10 Impact factor: 5.103

2. Involvement of the mutated M protein in altered budding polarity of a pantropic mutant, F1-R, of Sendai virus.

Authors: M Tashiro; N L McQueen; J T Seto; H D Klenk; R Rott
Journal: J Virol Date: 1996-09 Impact factor: 5.103

3. Positive and negative host factors for Sendai virus transcription and their organ distribution in rat.

Authors: T Takagi; M Iwama; K Seta; T Kanda; T Tsukamoto; S Tominaga; K Mizumoto
Journal: Arch Virol Date: 1996 Impact factor: 2.574

4. The Sendai virus nucleocapsid exists in at least four different helical states.

Authors: E H Egelman; S S Wu; M Amrein; A Portner; G Murti
Journal: J Virol Date: 1989-05 Impact factor: 5.103

5. A field isolate of Sendai virus: its high virulence to mice and genetic divergence form prototype strains.

Authors: T Sakaguchi; K Kiyotani; M Sakaki; Y Fujii; T Yoshida
Journal: Arch Virol Date: 1994 Impact factor: 2.574

6. Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV.

Authors: Bart Jones; Xiaoyan Zhan; Vasiliy Mishin; Karen S Slobod; Sherri Surman; Charles J Russell; Allen Portner; Julia L Hurwitz
Journal: Vaccine Date: 2009-02-04 Impact factor: 3.641

Sendai virus.

1. Altered budding site of a pantropic mutant of Sendai virus, F1-R, in polarized epithelial cells.

2. Involvement of the mutated M protein in altered budding polarity of a pantropic mutant, F1-R, of Sendai virus.

3. Positive and negative host factors for Sendai virus transcription and their organ distribution in rat.

4. The Sendai virus nucleocapsid exists in at least four different helical states.

5. A field isolate of Sendai virus: its high virulence to mice and genetic divergence form prototype strains.

6. Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV.

7. Pneumotropism of Sendai virus in relation to protease-mediated activation in mouse lungs.

8. Macrophage polykaryon formation in vitro by peritoneal cells from mice given injections of sodium periodate.

9. Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicity.

10. Survey of virally mediated permeability changes.